Painful diabetic peripheral neuropathy: Consensus recommendations on diagnosis, assessment and management

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 7, 2011, Pages 629-638

  Tesfaye, S ^a   Vileikyte, L ^b   Rayman, G ^c   Sindrup, S H ^d   Perkins, B A ^e   Baconja, M ^f   Vinik, A I ^g   Boulton, A J M ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Diabetic neuropathy; Painful diabetic peripheral neuropathy; Treatment

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIOXIDANT; CAPSAICIN; CARBAMAZEPINE; DULOXETINE; GABAPENTIN; IMIPRAMINE; MORPHINE; MORPHINE SULFATE; NORADRENALIN UPTAKE INHIBITOR; OPIATE DERIVATIVE; OXYCODONE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; THIOCTIC ACID; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT;

CARDIOVASCULAR RISK; CHRONIC DRUG ADMINISTRATION; COMORBIDITY; CONSENSUS DEVELOPMENT; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ELECTROSTIMULATION; HUMAN; LONG TERM CARE; MOOD; NEUROPATHIC PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SPINAL CORD STIMULATION; TOPICAL TREATMENT; CONSENSUS; DIABETIC NEUROPATHIES; DISEASE MANAGEMENT; PAIN; PRACTICE GUIDELINE;

ACTIVITIES OF DAILY LIVING; ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; CONSENSUS; DIABETIC NEUROPATHIES; DISEASE MANAGEMENT; HUMANS; PAIN; QUALITY OF LIFE;

EID: 80053605052     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1225     Document Type: Review

References (61)

1. Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity and treatments. Diabetes Care 2010; 33: 2285-2293.
2. Boulton AJM, Malik RA, Arezzo J, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004; 27: 1458-1486.
3. Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH; EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008; 31(7): 1360-1366.
4. Carrington AL, Shaw JE, Van Schie CMH, Abbott CA, Vileikyte L, Boulton AJM. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 2002; 25: 2010-2015.
5. Tesfaye S, Boulton AJM (eds). Diabetic Neuropathy. Oxford: Oxford University Press: 2009.
6. Treede R-D, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630-1635.
7. Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 2006; 22: 681-685.
8. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003; 19(Suppl 1): S2-S8.
9. Vinik A, Zlateva G, Cheung R, Murphy K, Emir B, Whalen E. Understanding the impact of pain response on changes in function, quality of life, and sleep interference in patients with painful diabetic peripheral neuropathy and post-herpetic neuralgia treated with pregabalin. J Pain 2010; 11: S17.
10. Vileikyte L, Leventhal H, Gonzalez J, et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care 2005; 28: 2378-2383.
11. Vileikyte L, Peyrot M, Gonzalez JS, et al. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study. Diabetologia 2009; 52: 1265-1273.
12. Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005; 30: 374-385.
13. Sankar A, Selvarajah D, Gandhi R, Oleolo M, Emery C, Tesfaye S. Significant impact of mood disturbances of pain perception in painful DPN:time to re-evaluate current practice? Diabetologia 2010; 53(Suppl 1): S446.
14. Tesfaye S, Malik RA, Harris N, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy and rapid glycaemic control (insulin neuritis). Diabetologia 1996; 39: 329-335.
15. Vinik A. The approach to the management of the patient with neuropathic pain. J Clin Endocrinol Metab 2010; 95(11): 4802-4811.
16. Daousi C, McFarlane IA, Woodward A, Nurmikko TJ, Bendred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a control comparison of people with and without diabetes. Diabet Med 2004; 21: 976-982.
17. Tesfaye S, Kempler P. Painful diabetic neuropathy. Diabetologia 2005; 48: 805-807.
18. Oyibo SO, Prasad YDM, Jackson NJ Boulton AJM. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002; 19: 870-873.
19. Eaton SE, Harris ND, Ibrahim S, et al. Differences insural nerve haemodynamics in painful and painless neuropathy. Diabetologia 2003; 934-939.
20. Quattrini C, Harris ND, Malik RA, Tesfaye S. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care 2007; 30: 655-659.
21. Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006; 29: 883-887.
22. Selvarajah D, Wilkinson ID, Gandhi R, Griffiths PD, Tesfaye S. Microvascular perfusion abnormalities of the Thalamus in painful but not painless diabetic polyneuropathy: a clue to the pathogenesis of pain in type 1 diabetes. Diabetes Care 2011; 34(3): 718-20.
23. Gandhi R, Marques JLB, Selvarajah D, et al. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Diabetes Care 2010; 33: 1585-1590.
24. Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetes neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28: 1-7.
25. Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010; 17(8): 1010-1018.
26. Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the neuropathic pain symptom inventory. Pain 2004; 108(3): 248-257.
27. Zelman DC, Gore M, Dukes E, Tai KS, Brandenburg N. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy. J Pain Symptom Manage 2005; 29(4): 401-410.
28. Backonja MM, Krause SJ. Neuropathic pain questionnaire-short form. Clin J Pain 2003; 19(5): 315.
29. Bennett M. The LANSS pain scale: the leeds assessment of neuropathic symptoms and signs. Pain 2001; 92: 147-157.
30. Melzack R. The short-form McGill pain questionnaire. Pain 1987; 30: 191-197.
31. Vileikyte L, Peyrot M, Bundy EC, et al. The development and validation of a neuropathy and foot ulcer specific Quality of Life Instrument. Diabetes Care 2003; 26: 2549-2555.
32. Vinik E, Hayes R, Oglesby A, Bastyr E, Barlow P, Ford-Molvik S, Vinik A. The development and validation of the Norfolk QOL-DN a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther 2005; 7(3): 497-508.
33. Poole HM, Murphy P, Nurmikko TJ. Development and preliminary validation of the NePIQoL: a quality-of-life measure for neuropathic pain. J Pain Symptom Manage 2009; 37: 233-245.
34. Zigmond AS, Snaith RP. The hospital anxiety depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
35. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150: 573-581.
36. Sindrup S, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 2005; 96: 399-409.
37. Ray WA, Meredith S, Thapa PB, et al. Cyclic antidepressantsnd the risk of sudden cardiac death. Clin Pharmacol Ther 2004; 75: 234-241.
38. Kajdasz DK, Iyengar S, Desaiah D, et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicentre, randomised, double-blind, placebo-controlled, parallel-group studies. Clin Ther 2007; 29(Suppl 2): 536-546.
39. Backonja MM, Beydoun A, Edwards KR, et al. Gabapentin for symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998; 280: 1831-1836.
40. Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomised, controlled trials across a range of doses. Diabetes Care 2008; 31: 1448-1454.
41. Donofrio PD, Raskin P, Rosenthal NR, et al.; CAPSS-141 Study Group. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study. Clin Ther 2005; 27(9): 1420-1431.
42. Kastrup J, Petersen P, Dejard A, et al. Intravenous lidocaine infusion: a new treatment of chronic painful diabetic neuropathy. Pain 1987; 28: 69-75.
43. Jarvis B, Coukell AJ. Mexilitene: a review of its therapeutic use in painful diabetic neuropathy. Drugs 1998; 56: 691-708.
44. Harati Y, Gooch C, Swenson M, et al. Double-blind randomised trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998; 50: 1842-1846.
45. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomised controlled trial. Neurology 2003; 60: 927-934.
46. Bansal D, Bhansali A, Hota D, Chakrabarti A, Dutta P. Amitriptyline vs pregabalin in painful diabetic neuropathy: a randomised double-blind clinical trial. Diabetic Med 2009; 26: 1019-1026.
47. Gilron I, Bailey JM, Tu D, et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009; 374(9697): 1252-1261.
48. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 1324-1334.
49. Zhang WY, Li Wan PoA. The effectiveness of topically applied capsaicin: a meta-analysis. Eur J Clin Pharm 1994; 46: 517-522.
50. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with alpha-lipoic acid: a meta-analysis. Diabetic Med 2004; 21: 114-121.
51. Freynhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ 2009; 339: b3002.
52. Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage 2007; 12: 13-21.
53. Attal N, Cruccu G, Baron R, et al.; European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17(9): 1113-e88.
54. NICE Clinical Guideline 96: Neuropathic Pain. The pharmacological management of neuropathic pain in adults in non-specialist settings, March 2010. Available at: [Accessed 26 July 2011].
55. Abuaisha BB, Constanzi JB, Boulton AJM. Acupuncture for the treatment of chronic painful diabetic neuropathy: a long-term study. Diabetes Res Clin Pract 1998; 39: 115-121.
56. Leonard DR, Farooqu MH, Myers S. Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomised placebo-controlled study with monochromatic infrared treatment. Diabetes Care 2004; 27: 168-172.
57. Zinman LH, Ngo M, Ng ET, et al. Low-intensity laser therapy for painful symptoms of diabetic sensorimotor polyneuropathy∼: a controlled trial. Diabetes Care 2004; 27: 921-924.
58. Oyibo S, Breislin K, Boulton AJM. Electrical stimulation therapy through stocking electrodes for painful diabetic neuropathy: a double-blind controlledrossover study. Diabet Med 2004; 21: 940-944.
59. Bosi E, Conti M, Vermigli C, et al. Effectiveness of frequency modulated electromagnetic neural stimulation in the treatment of diabetic peripheral neuropathy. Diabetologia 2005; 48(5): 817-823.
60. Reichstein L, Labrenz S, Ziegler D, Martin S. Effective treatment of symptomatic diabetic polyneuropathy by high frequency external muscle stimulation. Diabetologia 2005; 48(5): 824-828.
61. Tesfaye S, Watt J, Benbow SJ, et al. Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996; 348: 1698-1701.